HAILY SWINGER: Open Payments
NPI 1609387414 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 6 payments from 4 companies in 2025. Trend: 2023 $27 · 2024 $487 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $107 |
| Sumitomo Pharma America, Inc. | 3 | $81 |
| Organon LLC | 1 | $28 |
| Becton, Dickinson and Company | 1 | $16 |
Products named: Veozah, GEMTESA, NEXPLANON, Aptra.
Industry payments across WA — which companies pay providers there.
